1 – 8 of 8
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
(
- Contribution to journal › Article
- 2009
-
Mark
Oncogenic flt3 receptors display different specificity and kinetics of autophosphorylation.
(
- Contribution to journal › Article
-
Mark
A role of Gab2 association in Flt3 ITD mediated Stat5 phosphorylation and cell survival.
(
- Contribution to journal › Article
- 2008
-
Mark
Hypomethylation and apoptosis in 5-azacytidine-treated myeloid cells
(
- Contribution to journal › Article
-
Mark
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines
(
- Contribution to journal › Letter
-
Mark
Maintenance Treatment with 5-Azacitidine for Patients with High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia Following MDS (MDS-AML) in Complete Remission (CR) after Induction Chemotherapy
(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following Myelodysplastic syndrome
(
- Contribution to journal › Article
- 2006
-
Mark
A pharmacodynamic study of 5-azacytidine in the P39 cell line
(
- Contribution to journal › Article